S
Sociedade Hospitalar Angelina Caron | Departamento de Ensino e Pesquisa
Research site
(Unclaimed)
Site insights
Top conditions
Top treatments
Milvexian
Simvastatin
Statin
Evolocumab
Triglycerides
Rosuvastatin
Aldosterone bloCkade
Pravastatin
Pantoprazole
Pemafibrate
Curious how this site stacks up to its peers?
Data sourced from clinicaltrials.gov
Work at this site?
CTV for research professionals allows users to enhance their site’s profile, add contact information, and more.
Active trials
3 of 9 total trials
The purpose of this study is to evaluate that milvexian is superior to placebo, in addition to standard-of-care, in reducing the risk of major advers...
Enrolling
Acute Coronary Syndrome
Drug: Milvexian
Other: Placebo
The purpose of this study is to evaluate whether milvexian compared to placebo reduce the risk of recurrent ischemic stroke.
Enrolling
Ischemic Stroke; Ischemic Attack, Transient
Drug: Placebo
Drug: Milvexian
The purpose of this study is to evaluate if milvexian is at least as effective as apixaban for reducing the risk of the composite stroke and non-cent...
Active, not recruiting
Atrial Fibrillation
Drug: Apixaban Placebo
Drug: Milvexian
Trial sponsors
Clinical trials
Research sites
Resources
Legal
© Copyright 2025 Veeva Systems